Delivery Order SPE2DB22D2103-SPE2DB25FR9WE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Trintellix 5 mg tablets (30-count unit) valued at $1,263.99. This firm fixed-price delivery order, which matures on June 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $5,667.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trintellix 5 mg tablets (30-count units) on June 12, 2025, with an ultimate completion date of June 13, 2025. The contract was not set-aside and represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will occur at the vendor's corporate office location in Conshohocken, PA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trintellix 20 mg tablets (30-count) with a ceiling value of $5,763.62. This non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is fulfilling this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trintellix 10 mg tablets (30-count) under a firm fixed-price contract valued at $4,781.16. This is a non-set-aside competitive award with an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,356.39 to supply Trintellix 20 mg tablets (30-count) with a firm fixed price structure and completion date of September 22, 2025. This non-set-aside, competitively awarded contract represents a standard pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, carries a ceiling value of $3,018.60. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The product will be delivered...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trintellix 20 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $2,747.66, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract was completed on August 8, 2025, with performance fulfilled at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,392.88 to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. The pharmaceutical will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,955.35 on August 4, 2025, for the supply of Trintellix 20 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9WEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $31,723.92 to AmerisourceBergen Drug Corp for the supply of Trintellix 5 mg tablets (30-count units) on September 25, 2025, with completion scheduled for September 26, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad spectrum of pharmaceutical products and medical supplies to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Trintellix (vortioxetine), a neuropsychiatric medication, aligns with the company's established portfolio of therapeutic products supporting military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.7k | 9/25/25 |